Aethlon Medical Inc at LD Micro Invitational Conference Transcript
Okay. Getting settled in, ready for our next presentation with Aethlon Medical. I'd like to introduce to you, Mr. Jim Frakes.
Thank you very much. Thanks for coming, everyone. I'll let you read our forward-looking statement at your convenience.
A few investment highlights on Aethlon. We're focused on combating cancer and infectious diseases with development of first-in-class immunotherapy therapeutic technologies. We're led by a seasoned industry -- group of industry executives with extensive development and commercialization experience.
Our product, the Hemopurifier, has demonstrated the capture of disease promoting exosomes and circulating viruses in clinical trials and emergency use. And the Hemopurifier has been designated as a Breakthrough Device by the US FDA for two indications. We're well capitalized with a solid cash position.
Now I'd like to introduce my colleague, Guy Cipriani, the Chief Business Officer of Aethlon, to take you through the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |